Click for best price
Biologic Therapeutics Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 304100 million
|
Forecast Market size by 2030 |
US$ 467710 million
|
| Growth Rate |
CAGR of 6.3% |
Number of Pages |
114 Pages |
This research report provides a comprehensive analysis of the Biologic Therapeutics Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biologic Therapeutics Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biologic Therapeutics Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Biologic Therapeutics Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biologic Therapeutics Drugs market presents opportunities for various stakeholders, including Rheumatoid Arthritis, Anemia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biologic Therapeutics Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biologic Therapeutics Drugs market was valued at US$ 304100 million in 2023 and is projected to reach US$ 467710 million by 2030, at a CAGR of 6.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Biologic Therapeutics Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biologic Therapeutics Drugs market.
Market Overview: The report provides a comprehensive overview of the Biologic Therapeutics Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Avian Cell Culture, Yeast), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biologic Therapeutics Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biologic Therapeutics Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biologic Therapeutics Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biologic Therapeutics Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biologic Therapeutics Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biologic Therapeutics Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biologic Therapeutics Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biologic Therapeutics Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biologic Therapeutics Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Market segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Global Biologic Therapeutics Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologic Therapeutics Drugs, market overview.
Chapter 2: Global Biologic Therapeutics Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologic Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biologic Therapeutics Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biologic Therapeutics Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 304100 million
|
| Forecast Market size by 2030 |
US$ 467710 million
|
| Growth Rate |
CAGR of 6.3% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biologic Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologic Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologic Therapeutics Drugs Overall Market Size
2.1 Global Biologic Therapeutics Drugs Market Size: 2023 VS 2030
2.2 Global Biologic Therapeutics Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Biologic Therapeutics Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Biologic Therapeutics Drugs Players in Global Market
3.2 Top Global Biologic Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Biologic Therapeutics Drugs Revenue by Companies
3.4 Global Biologic Therapeutics Drugs Sales by Companies
3.5 Global Biologic Therapeutics Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Biologic Therapeutics Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Biologic Therapeutics Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologic Therapeutics Drugs Players in Global Market
3.8.1 List of Global Tier 1 Biologic Therapeutics Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologic Therapeutics Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologic Therapeutics Drugs Market Size Markets, 2023 & 2030
4.1.2 Avian Cell Culture
4.1.3 Yeast
4.1.4 Bacteria
4.1.5 Insects Cell Culture
4.1.6 Transgenics
4.2 By Type - Global Biologic Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Biologic Therapeutics Drugs Revenue, 2019-2024
4.2.2 By Type - Global Biologic Therapeutics Drugs Revenue, 2025-2030
4.2.3 By Type - Global Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Biologic Therapeutics Drugs Sales & Forecasts
4.3.1 By Type - Global Biologic Therapeutics Drugs Sales, 2019-2024
4.3.2 By Type - Global Biologic Therapeutics Drugs Sales, 2025-2030
4.3.3 By Type - Global Biologic Therapeutics Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Biologic Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologic Therapeutics Drugs Market Size, 2023 & 2030
5.1.2 Rheumatoid Arthritis
5.1.3 Anemia
5.1.4 Cancer
5.1.5 Diabetes
5.1.6 Others
5.2 By Application - Global Biologic Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Biologic Therapeutics Drugs Revenue, 2019-2024
5.2.2 By Application - Global Biologic Therapeutics Drugs Revenue, 2025-2030
5.2.3 By Application - Global Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Biologic Therapeutics Drugs Sales & Forecasts
5.3.1 By Application - Global Biologic Therapeutics Drugs Sales, 2019-2024
5.3.2 By Application - Global Biologic Therapeutics Drugs Sales, 2025-2030
5.3.3 By Application - Global Biologic Therapeutics Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Biologic Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Biologic Therapeutics Drugs Market Size, 2023 & 2030
6.2 By Region - Global Biologic Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Biologic Therapeutics Drugs Revenue, 2019-2024
6.2.2 By Region - Global Biologic Therapeutics Drugs Revenue, 2025-2030
6.2.3 By Region - Global Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Biologic Therapeutics Drugs Sales & Forecasts
6.3.1 By Region - Global Biologic Therapeutics Drugs Sales, 2019-2024
6.3.2 By Region - Global Biologic Therapeutics Drugs Sales, 2025-2030
6.3.3 By Region - Global Biologic Therapeutics Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Biologic Therapeutics Drugs Revenue, 2019-2030
6.4.2 By Country - North America Biologic Therapeutics Drugs Sales, 2019-2030
6.4.3 US Biologic Therapeutics Drugs Market Size, 2019-2030
6.4.4 Canada Biologic Therapeutics Drugs Market Size, 2019-2030
6.4.5 Mexico Biologic Therapeutics Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Biologic Therapeutics Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Biologic Therapeutics Drugs Sales, 2019-2030
6.5.3 Germany Biologic Therapeutics Drugs Market Size, 2019-2030
6.5.4 France Biologic Therapeutics Drugs Market Size, 2019-2030
6.5.5 U.K. Biologic Therapeutics Drugs Market Size, 2019-2030
6.5.6 Italy Biologic Therapeutics Drugs Market Size, 2019-2030
6.5.7 Russia Biologic Therapeutics Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Biologic Therapeutics Drugs Market Size, 2019-2030
6.5.9 Benelux Biologic Therapeutics Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Biologic Therapeutics Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Biologic Therapeutics Drugs Sales, 2019-2030
6.6.3 China Biologic Therapeutics Drugs Market Size, 2019-2030
6.6.4 Japan Biologic Therapeutics Drugs Market Size, 2019-2030
6.6.5 South Korea Biologic Therapeutics Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Biologic Therapeutics Drugs Market Size, 2019-2030
6.6.7 India Biologic Therapeutics Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Biologic Therapeutics Drugs Revenue, 2019-2030
6.7.2 By Country - South America Biologic Therapeutics Drugs Sales, 2019-2030
6.7.3 Brazil Biologic Therapeutics Drugs Market Size, 2019-2030
6.7.4 Argentina Biologic Therapeutics Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologic Therapeutics Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Biologic Therapeutics Drugs Sales, 2019-2030
6.8.3 Turkey Biologic Therapeutics Drugs Market Size, 2019-2030
6.8.4 Israel Biologic Therapeutics Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Biologic Therapeutics Drugs Market Size, 2019-2030
6.8.6 UAE Biologic Therapeutics Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Biologic Therapeutics Drugs Major Product Offerings
7.1.4 Pfizer Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Biologic Therapeutics Drugs Major Product Offerings
7.2.4 AstraZeneca Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Biologic Therapeutics Drugs Major Product Offerings
7.3.4 Novartis Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Novartis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Biologic Therapeutics Drugs Major Product Offerings
7.4.4 Merck Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 Smith Medical
7.5.1 Smith Medical Company Summary
7.5.2 Smith Medical Business Overview
7.5.3 Smith Medical Biologic Therapeutics Drugs Major Product Offerings
7.5.4 Smith Medical Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Smith Medical Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Concord Biotech
7.7.1 Concord Biotech Company Summary
7.7.2 Concord Biotech Business Overview
7.7.3 Concord Biotech Biologic Therapeutics Drugs Major Product Offerings
7.7.4 Concord Biotech Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Concord Biotech Key News & Latest Developments
7.8 Aurobindo Pharma
7.8.1 Aurobindo Pharma Company Summary
7.8.2 Aurobindo Pharma Business Overview
7.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Major Product Offerings
7.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Aurobindo Pharma Key News & Latest Developments
7.9 H. Lundbeck
7.9.1 H. Lundbeck Company Summary
7.9.2 H. Lundbeck Business Overview
7.9.3 H. Lundbeck Biologic Therapeutics Drugs Major Product Offerings
7.9.4 H. Lundbeck Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.9.5 H. Lundbeck Key News & Latest Developments
7.10 Retractable Technologies
7.10.1 Retractable Technologies Company Summary
7.10.2 Retractable Technologies Business Overview
7.10.3 Retractable Technologies Biologic Therapeutics Drugs Major Product Offerings
7.10.4 Retractable Technologies Biologic Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Retractable Technologies Key News & Latest Developments
8 Global Biologic Therapeutics Drugs Production Capacity, Analysis
8.1 Global Biologic Therapeutics Drugs Production Capacity, 2019-2030
8.2 Biologic Therapeutics Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologic Therapeutics Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologic Therapeutics Drugs Supply Chain Analysis
10.1 Biologic Therapeutics Drugs Industry Value Chain
10.2 Biologic Therapeutics Drugs Upstream Market
10.3 Biologic Therapeutics Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologic Therapeutics Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biologic Therapeutics Drugs in Global Market
Table 2. Top Biologic Therapeutics Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Biologic Therapeutics Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Biologic Therapeutics Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Biologic Therapeutics Drugs Sales by Companies, (Units), 2019-2024
Table 6. Global Biologic Therapeutics Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Biologic Therapeutics Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Biologic Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Biologic Therapeutics Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologic Therapeutics Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Biologic Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Biologic Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Biologic Therapeutics Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Biologic Therapeutics Drugs Sales (Units), 2019-2024
Table 15. By Type - Global Biologic Therapeutics Drugs Sales (Units), 2025-2030
Table 16. By Application ? Global Biologic Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Biologic Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Biologic Therapeutics Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Biologic Therapeutics Drugs Sales (Units), 2019-2024
Table 20. By Application - Global Biologic Therapeutics Drugs Sales (Units), 2025-2030
Table 21. By Region ? Global Biologic Therapeutics Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Biologic Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Biologic Therapeutics Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Biologic Therapeutics Drugs Sales (Units), 2019-2024
Table 25. By Region - Global Biologic Therapeutics Drugs Sales (Units), 2025-2030
Table 26. By Country - North America Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Biologic Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Biologic Therapeutics Drugs Sales, (Units), 2019-2024
Table 29. By Country - North America Biologic Therapeutics Drugs Sales, (Units), 2025-2030
Table 30. By Country - Europe Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Biologic Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Biologic Therapeutics Drugs Sales, (Units), 2019-2024
Table 33. By Country - Europe Biologic Therapeutics Drugs Sales, (Units), 2025-2030
Table 34. By Region - Asia Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Biologic Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Biologic Therapeutics Drugs Sales, (Units), 2019-2024
Table 37. By Region - Asia Biologic Therapeutics Drugs Sales, (Units), 2025-2030
Table 38. By Country - South America Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Biologic Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Biologic Therapeutics Drugs Sales, (Units), 2019-2024
Table 41. By Country - South America Biologic Therapeutics Drugs Sales, (Units), 2025-2030
Table 42. By Country - Middle East & Africa Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Biologic Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Biologic Therapeutics Drugs Sales, (Units), 2019-2024
Table 45. By Country - Middle East & Africa Biologic Therapeutics Drugs Sales, (Units), 2025-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer Biologic Therapeutics Drugs Product Offerings
Table 48. Pfizer Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Biologic Therapeutics Drugs Product Offerings
Table 52. AstraZeneca Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Biologic Therapeutics Drugs Product Offerings
Table 56. Novartis Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Novartis Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Biologic Therapeutics Drugs Product Offerings
Table 60. Merck Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. Smith Medical Company Summary
Table 63. Smith Medical Biologic Therapeutics Drugs Product Offerings
Table 64. Smith Medical Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Smith Medical Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Biologic Therapeutics Drugs Product Offerings
Table 68. GlaxoSmithKline Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Concord Biotech Company Summary
Table 71. Concord Biotech Biologic Therapeutics Drugs Product Offerings
Table 72. Concord Biotech Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Concord Biotech Key News & Latest Developments
Table 74. Aurobindo Pharma Company Summary
Table 75. Aurobindo Pharma Biologic Therapeutics Drugs Product Offerings
Table 76. Aurobindo Pharma Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Aurobindo Pharma Key News & Latest Developments
Table 78. H. Lundbeck Company Summary
Table 79. H. Lundbeck Biologic Therapeutics Drugs Product Offerings
Table 80. H. Lundbeck Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. H. Lundbeck Key News & Latest Developments
Table 82. Retractable Technologies Company Summary
Table 83. Retractable Technologies Biologic Therapeutics Drugs Product Offerings
Table 84. Retractable Technologies Biologic Therapeutics Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Retractable Technologies Key News & Latest Developments
Table 86. Biologic Therapeutics Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2022-2024 (Units)
Table 87. Global Biologic Therapeutics Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Biologic Therapeutics Drugs Production by Region, 2019-2024 (Units)
Table 89. Global Biologic Therapeutics Drugs Production by Region, 2025-2030 (Units)
Table 90. Biologic Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 91. Biologic Therapeutics Drugs Market Drivers in Global Market
Table 92. Biologic Therapeutics Drugs Market Restraints in Global Market
Table 93. Biologic Therapeutics Drugs Raw Materials
Table 94. Biologic Therapeutics Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Biologic Therapeutics Drugs Downstream
Table 96. Biologic Therapeutics Drugs Downstream Clients in Global Market
Table 97. Biologic Therapeutics Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biologic Therapeutics Drugs Segment by Type in 2023
Figure 2. Biologic Therapeutics Drugs Segment by Application in 2023
Figure 3. Global Biologic Therapeutics Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Biologic Therapeutics Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Biologic Therapeutics Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Biologic Therapeutics Drugs Sales in Global Market: 2019-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologic Therapeutics Drugs Revenue in 2023
Figure 9. By Type - Global Biologic Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Biologic Therapeutics Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Biologic Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Biologic Therapeutics Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Biologic Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Biologic Therapeutics Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 23. US Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 28. Germany Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 37. China Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Biologic Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Biologic Therapeutics Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Biologic Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Biologic Therapeutics Drugs Production Capacity (Units), 2019-2030
Figure 53. The Percentage of Production Biologic Therapeutics Drugs by Region, 2023 VS 2030
Figure 54. Biologic Therapeutics Drugs Industry Value Chain
Figure 55. Marketing Channels
